Prestwick3_000161

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 7 USDMF, 5 CEP/COS, 1 JDMF, 2 EU WC, 7 NDC API, 5 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

FINISHED DOSAGE FORMULATIONS

176 FDF Dossiers, 61 FDA Orange Book, 35 Europe, 3 Canada, 1 Australia, 59 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 50MG;300MG;120MG, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 12 SPI Pharma, 12 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 4 ACG Worldwide, 4 Actylis, 2 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 17 BASF, 1 CD Formulation, 7 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 14 Kerry, 4 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 18 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 2 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 6 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 34 Thickeners and Stabilizers, 30 Direct Compression, 28 Granulation, 27 Disintegrants & Superdisintegrants, 23 Lubricants & Glidants, 17 Coating Systems & Additives, 16 Film Formers & Plasticizers, 15 Co-Processed Excipients, 14 Parenteral, 14 Taste Masking, 13 Solubilizers, 9 Chewable & Orodispersible Aids, 9 Controlled & Modified Release, 8 Empty Capsules, 8 Topical, 7 Rheology Modifiers, 7 Emulsifying Agents, 3 API Stability Enhancers, 3 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 15 Regulatory FDF Prices

MARKET PLACE

12 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 3 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 88235 / DOSAGE - SYRUP;ORAL - 50MG/5ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ISONIAZID(UNII: V83O1VOZ8L) (ISONIAZID - UNII:V83O1VOZ8L)	ISONIAZID	50mg in 5

Inactive Ingredients

Ingredient Name	A-S Medication Solutions LLC	Bryant Ranch Prepack	Mikart, LLC
CITRIC ACID MONOHYDRATE(2968PHW8QP)
GLYCERIN(PDC6A3C0OX)
METHYLPARABEN(A2I8C7HI9T)
POTASSIUM SORBATE(1VPU26JZZ4)
PROPYLPARABEN(Z8IX2SC1OH)
SORBITOL(506T60A25R)

Drug Product Composition: Prestwick3_000161